In conclusion, FD attenuates BLM‐induced pulmonary inflammation and fibrosis through suppressing the activation of NALP3 inflammasome and the IL‐1β/IL‐1R1/MyD88/NF‐κB signalling pathway. The gene discussed is NLRP3; the disease is inflammation.